Abstract
Nocturnal polyuria, nocturnal detrusor overactivity and high arousal thresholds are central in the pathogenesis of enuresis. An underlying mechanism on the brainstem level is probably common to these mechanisms. Enuretic children have an increased risk for psychosocial comorbidity. The primary evaluation of the enuretic child is usually straightforward, with no radiology or invasive procedures required, and can be carried out by any adequately educated nurse or physician. The first-line treatment, once the few cases with underlying disorders, such as diabetes, kidney disease or urogenital malformations, have been ruled out, is the enuresis alarm, which has a definite curative potential but requires much work and motivation. For families not able to comply with the alarm, desmopressin should be the treatment of choice. In therapy-resistant cases, occult constipation needs to be ruled out, and then anticholinergic treatment—often combined with desmopressin—can be tried. In situations when all other treatments have failed, imipramine treatment is warranted, provided the cardiac risks are taken into account.
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.References
Nevéus T, von Gontard A, Hoebeke P, Hjälmås K, Bauer S, Bower W, Jørgensen TM, Rittig S, Vande Walle J, Yeung CK, Djurhuus JC (2006) The standardization of terminology of lower urinary tract function in children and adolescents: report from the standardisation committee of the International Children's Continence Society (ICCS). J Urol 176:314–324
Bower WF, Moore KH, Shepherd RB, Adams RD (1996) The epidemiology of childhood enuresis in Australia. Br J Urol 78:602–606
Rittig S, Knudsen UB, Nørgaard JP, Pedersen EB, Djurhuus JC (1989) Abnormal diurnal rhythm of plasma Vasopressin and urinary output in patients with enuresis. Am J Physiol 256:F664–F671
Rasmussen PV, Kirk J, Borup K, Nørgaard JP, Djurhuus JC (1996) Enuresis nocturna can be provoked in normal healthy children by increasing the nocturnal urine output. Scand J Urol Nephrol 30:57–61
Hunsballe JM, Hansen TK, Rittig S, Nørgaard JP, Pedersen EB, Djurhuus JC (1995) Polyuric and non-polyuric bedwetting—pathogenetic differences in nocturnal enuresis. Scand J Urol Nephrol S173:77–79
Mattsson S, Lindström S (1994) Diuresis and voiding pattern in healthy schoolchildren. Br J Urol 76:783–789
Fonseca EG, Bordallo AP, Garcia PK, Munhoz C, Silva CP (2009) Lower urinary tract symptoms in enuretic and nonenuretic children. J Urol 182[4 Suppl]:1978–1983
Nevéus T, Tuvemo T, Läckgren G, Stenberg A (2001) Bladder capacity and renal concentrating ability in enuresis—pathogenic implications. J Urol 165:2022–2025
Yeung CK, Chiu HN, Sit FK (1999) Bladder dysfunction in children with refractory monosymptomatic primary nocturnal enuresis. J Urol 162:1049–1055
Page ME, Valentino RJ (1994) Locus coeruleus activation by physiological challenges. Brain Res Bull 35:557–560
Nevéus T, Hetta J, Cnattingius S, Tuvemo T, Läckgren G, Olsson U, Stenberg A (1999) Depth of sleep and sleep habits among enuretic and incontinent children. Acta Paediatr 88:748–752
Wolfish NM, Pivik RT, Busby KA (1997) Elevated sleep arousal thresholds in enuretic boys: clinical implications. Acta Paediatr 86:381–384
Kayama Y, Koyama Y (1998) Brainstem neural mechanisms of sleep and wakefulness. Eur Urol 33:12–15
Holstege G, Griffiths D, De Wall H, Dalm E (1986) Anatomical and physiological observations on supraspinal control of bladder and urethral sphincter muscles in the cat. J Comp Neurol 250:449–461
Lightman SL, Todd K, Everitt BJ (1984) Ascending noradrenergic projections from the brainstem: evidence for a major role in the regulation of blood pressure and Vasopressin secretion. Exp Brain Res 55:145–151
Ornitz EM, Russell AT, Hanna GL, Gabikian P, Gehricke JG, Song D, Guthrie D (1999) Prepulse inhibition of startle and the neurobiology of primary nocturnal enuresis. Biol Psychiatry 45:1455–1466
Danysz W, Kostowski W, Hauptmann M (1985) Evidence for the locus coeruleus involvement in desipramine action in animal models of depression. Pol J Pharmacol Pharm 37:855–864
Roche EF, Menon A, Gill D, Hoey H (2005) Clinical presentation of type 1 diabetes. Pediatr Diab 6:75–78
Yazbeck S, Schick E, O'Regan S (1987) Relevance of constipation to enuresis, urinary tract infection and reflux. A review. Eur Urol 13:318–321
Umlauf MG, Chasens ER (2003) Sleep disordered breathing and nocturnal polyuria: nocturia and enuresis. Sleep Med Rev 7:403–411
Glazener CM, Evans JH (2002) Desmopressin for nocturnal enuresis. Cochrane Database Syst Rev:CD002112
Schulz-Juergensen S, Rieger M, Schaefer J, Neusuess A, Eggert P (2007) Effect of 1-desamino-8-d-arginine vasopressin on prepulse inhibition of startle supports a central etiology of primary monosymptomatic enuresis. J Pediatr 151:571–574
Hjälmås K, Hanson E, Hellström A-L, Kruse S, Sillén U (1998) Long-term treatment with desmopressin in children with primary monosymptomatic nocturnal enuresis: an open multicentre study. Swedish Enuresis Trial (SWEET) Group. Br J Urol 82:704–709
Robson WL, Nørgaard JP, Leung AK (1996) Hyponatremia in patients with nocturnal enuresis treated with DDAVP. Eur J Pediatr 155:959–962
Nevéus T, Eggert P, Evans J, Macedo A, Rittig S, Tekgül S, Vande Walle J, Yeung CK, Robson L (2010) Evaluation and treatment of monosymptomatic enuresis - a standardisation document from the International Children's Continence Society (ICCS). J Urol 183:441–447
Kruse S, Hellström A-L, Hjälmås K (1999) Daytime bladder dysfunction in therapy-resistant nocturnal enuresis. A pilot study in urotherapy. Scand J Urol Nephrol 33:49–52
Robson LM, Leung AK (2002) Urotherapy recommendations for bedwetting. J Natl Med Assoc 94:577–580
Harris LS, Purohit AP (1977) Bladder training and enuresis: a controlled trial. Behav Res Ther 11:289–297
Nevéus T, Läckgren G, Stenberg A, Nørgaard JP (2005) Anticholinergic treatment for nocturnal enuresis: current understanding and future expectations. Dialogues Pediatr Urol 26:9–11
Lovering JS, Tallett SE, McKendry BI (1988) Oxybutynin efficacy in the treatment of primary enuresis. Pediatrics 82:104–106
Austin PF, Ferguson G, Yan Y, Campigotto MJ, Royer ME, Coplen DE (2008) Combination therapy with desmopressin and an anticholinergic medication for nonresponders to desmopressin for monosymptomatic nocturnal enuresis: randomized, double-blind, placebo-controlled trial. Pediatrics 122:1027–1032
Gish P, Mosholder AD, Truffa M, Johann-Liang R (2009) Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult cases. J Pediatr 155:432–434
Oredsson AF, Jørgensen TM (1998) Changes in nocturnal bladder capacity during treatment with the bell and pad for monosymptomatic nocturnal enuresis. J Urol 160:166–169
Glazener CM, Evans JH (2007) Alarm interventions for nocturnal enuresis in children (Cochrane Review). The Cochrane Library. Update Software, Oxford
Morgan RTT (1978) Relapse and therapeutic response in the conditioning treatment of enuresis: a review of recent findings on intermittent reinforcement, overlearning and stimulus intensity. Behav Res Ther 16:273–279
Glazener CM, Evans JH (2000) Tricyclic and related drugs for nocturnal enuresis in children. Cochrane Database Syst Rev 2000:CD002117
Gepertz S, Nevéus T (2004) Imipramine for therapy resistant enuresis: a retrospective evaluation. J Urol 171:2607–2610
Varley CK (2000) Sudden death of a child treated with imipramine. Case study. J Child Adolesc Psychopharmachol 10:321–325
Seabrook JA, Gorodzinsky F, Freedman S (2005) Treatment of primary nocturnal enuresis: a randomized clinical trial comparing hypnotherapy and alarm therapy. Paediatr Child Health 10:609–610
Glazener CM, Evans J, Cheuk DK (2005) Complementary and miscellaneous interventions for nocturnal enuresis in children. Cochrane Database Syst Rev 18:CD005230
Glazener CM, Evans JH (2004) Simple behavioural and physical interventions for nocturnal enuresis in children. Cochrane Database Syst Rev:CD003637
Hirasing RA, van Leerdam FJ, Bolk-Bennink L, Janknegt RA (1997) Enuresis nocturna in adults. Scand J Urol Nephrol 31:533–536
Yeung CK, Sihoe JD, Sit FK, Bower WF, Sreedhar B, Lau J (2004) Characteristics of primary nocturnal enuresis in adults: an epidemiological study. BJU Int 93:341–345
Yeung CK, Sreedhar B, Sihoe JD, Sit FK, Lau J (2006) Differences in characteristics of nocturnal enuresis between children and adolescents: a critical appraisal from a large epidemiological study. BJU Int 97:1069–1073
Kuh D, Cardozo L, Hardy R (1999) Urinary incontinence in middle aged women: childhood enuresis and other lifetime risk factors in a British prospective cohort. J Epidemiol Community Health 53:453–458
Coyne KS, Kaplan SA, Chapple CR, Sexton CC, Kopp ZS, Bush EN, Aiyer LP (2009) Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS. BJU Int 103:24–32
Hägglöf B, Andrén O, Bergström E, Marklund L, Wendelius M (1997) Self-esteem before and after treatment in children with nocturnal enuresis and urinary incontinence. Scand J Urol Nephrol 31:79–82
Duel BP, Steinberg-Epstein R, Hill M, Lerner M (2003) A survey of voiding dysfunction in children with attention deficit-hyperactivity disorder. J Urol 170:1521–1524
Baeyens D, Roeyers H, Hoebeke P, Verte S, Van Hoecke E, Vande Walle J (2004) Attention deficit/hyperactivity disorder in children with nocturnal enuresis. J Urol 171:2576–2579
Elia J, Takeda T, Deberardinis R, Burke J, Accardo J, Ambrosini PJ, Blum NJ, Brown LW, Lantieri F, Berrettini W, Devoto M, Hakonarson H (2009) Nocturnal enuresis: a suggestive endophenotype marker for a subgroup of inattentive attention-deficit/hyperactivity disorder. J Pediatr 155:239–244, e5
von Gontard A, Mauer-Mucke K, Pluck J, Berner W, Lehmkuhl G (1999) Clinical behavioral problems in day- and night-wetting children. Pediatr Nephrol 13:662–667
Bijos A, Czerwionka-Szaflarska M, Mazur A, Romanczuk W (2008) The usefulness of ultrasound examination of the bowel as a method of assessment of functional chronic constipation in children. Pediatr Radiol 37:1247–1252
Author information
Authors and Affiliations
Corresponding author
Additional information
Answers to questions
1. B
2. C
3. D
4. D
Questions
Questions
(Answers appear following the reference list)
-
1.
Should a 5-year-old child be actively treated for enuresis?
-
a
Yes, enuresis is a socially handicapping condition and should be treated early
-
b
Usually not, but this depends on whether he/she is bothered by the bedwetting or not
-
c
Yes, enuresis is defined as bedwetting in a child 5 years old or more
-
d
Yes, but treatment should start with desmopressin, since the child is probably too young to be motivated for alarm therapy
-
a
-
2.
Why should imipramine not be a first-line therapy of enuresis?
-
a
We have insufficient evidence that it works
-
b
It is not curative
-
c
It is dangerous if overdosed
-
d
Enuresis is not a psychiatric disorder and should thus not be treated with antidepressants
-
a
-
3.
Why is the enuresis alarm recommended as a first-line therapy in enuresis?
-
a
It is cheap
-
b
It is curative
-
c
It is evidence-based
-
d
All of the above
-
e
It is easy to use
-
a
-
4.
Which of the following factors is not implicated by modern research as crucial in the pathogenesis of enuresis?
-
a
Uninhibited micturition reflex
-
b
Brainstem malfunction
-
c
Nocturnal polyuria
-
d
Neurosis
-
e
Upper airway obstruction
-
a
Rights and permissions
About this article
Cite this article
Nevéus, T. Nocturnal enuresis—theoretic background and practical guidelines. Pediatr Nephrol 26, 1207–1214 (2011). https://doi.org/10.1007/s00467-011-1762-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-011-1762-8